<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Contact thermal devices for the treatment of bleeding peptic ulcers</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Contact thermal devices for the treatment of bleeding peptic ulcers</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Contact thermal devices for the treatment of bleeding peptic ulcers</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John R Saltzman, MD, FACP, FACG, FASGE, AGAF</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Douglas A Howell, MD, FASGE, FACG</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anne C Travis, MD, MSc, FACG, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 18, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The treatment of bleeding peptic ulcers includes resuscitation, treatment with acid suppressive therapy, and application of endoscopic therapy for patients at high risk of further bleeding  (<a class="graphic graphic_table graphicRef52860" href="/z/d/graphic/52860.html" rel="external">table 1</a>). Several endoscopic approaches can be used to treat bleeding peptic ulcers, including use of contact thermal devices, endoscopic clips, and <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection.</p><p>This topic will review the use of contact thermal devices for the treatment of bleeding peptic ulcers. An overview of the treatment of bleeding peptic ulcers, issues to consider when deciding which specific endoscopic therapies to use, and treating bleeding ulcers with endoscopic clips, <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection, or argon plasma coagulation are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers"</a> and  <a class="medical medical_review" href="/z/d/html/2668.html" rel="external">"Endoscopic clip therapy in the gastrointestinal tract: Bleeding lesions and beyond", section on 'Bleeding peptic ulcers'</a> and  <a class="medical medical_review" href="/z/d/html/2576.html" rel="external">"Argon plasma coagulation in the management of gastrointestinal hemorrhage"</a>.)</p><p class="headingAnchor" id="H63423729"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>Contact thermal therapy is one option for treating ulcers with stigmata of recent hemorrhage  (<a class="graphic graphic_table graphicRef78607" href="/z/d/graphic/78607.html" rel="external">table 2</a>). It can also be used to treat patients with bleeding from Dieulafoy's lesions, Mallory-Weiss tears, and gastric antral vascular ectasias. (See  <a class="medical medical_review" href="/z/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers", section on 'Endoscopic therapy'</a> and  <a class="medical medical_review" href="/z/d/html/2644.html" rel="external">"Causes of upper gastrointestinal bleeding in adults", section on 'Specific causes'</a>.)</p><p>The appearance of ulcers can be described using the Forrest classification [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Class Ia: Spurting hemorrhage  (<a class="graphic graphic_picture graphicRef61646" href="/z/d/graphic/61646.html" rel="external">picture 1</a> and <a class="graphic graphic_movie graphicRef50116" href="/z/d/graphic/50116.html" rel="external">movie 1</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Class Ib: Oozing hemorrhage</p><p class="bulletIndent1"><span class="glyph">●</span>Class IIa: Nonbleeding visible vessel  (<a class="graphic graphic_picture graphicRef54960 graphicRef79058 graphicRef61604" href="/z/d/graphic/54960.html" rel="external">picture 2A-C</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Class IIb: Adherent clot  (<a class="graphic graphic_picture graphicRef76246" href="/z/d/graphic/76246.html" rel="external">picture 3</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Class IIc: Flat pigmented spot  (<a class="graphic graphic_picture graphicRef52497" href="/z/d/graphic/52497.html" rel="external">picture 4</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Class III: Clean ulcer base  (<a class="graphic graphic_picture graphicRef74032" href="/z/d/graphic/74032.html" rel="external">picture 5</a>)</p><p></p><p>Stigmata of recent hemorrhage are present if anything other than a clean ulcer base is seen. Patients with active bleeding (spurting or oozing) or a nonbleeding visible vessel are at high risk for further bleeding and require endoscopic therapy. Whether to treat an adherent clot depends on whether the clot can be gently removed, the location of the ulcer, the comfort of the endoscopist with treating adherent clots, and the availability of surgical and/or interventional radiology support. Patients with flat pigmented spots and clean ulcer bases are considered low-risk and do not require endoscopic therapy. (See  <a class="medical medical_review" href="/z/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers", section on 'Endoscopic therapy'</a> and  <a class="medical medical_review" href="/z/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers", section on 'Inpatient versus outpatient management'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">AVAILABLE DEVICES</span><span class="headingEndMark"> — </span>Three types of contact thermal devices have gained popularity due to their efficacy, safety profiles, ease of use, and portability:</p><p class="bulletIndent1"><span class="glyph">●</span>Multipolar probes (Gold Probe, Quicksilver Bipolar Probe, BICAP Superconductor, BiCOAG Bipolar Probe, Bipolar Hemostasis Probe)</p><p class="bulletIndent1"><span class="glyph">●</span>Heater probe (HeatProbe; no longer being produced) </p><p class="bulletIndent1"><span class="glyph">●</span>Monopolar probe (Coagrasper)</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Multipolar probes</span><span class="headingEndMark"> — </span>Multipolar electrocautery (MPEC) probes achieve hemostasis by heating the contacted tissue with electricity that passes between the alternating arrays of positive and the negative electrodes located within the tip of the probe. The electrical circuit is completed between two electrodes on the tip of the probe, so the circuit is completed locally and no grounding pad is required.</p><p>Tissue coagulation occurs at the tip or sides of the multipolar probe when the tissue temperature reaches approximately 70ºC [<a href="#rid2">2</a>]. The tissue's resistance to further coagulation increases exponentially once the tissue in contact with the MPEC probe has been completely desiccated. As a result, deep tissue coagulation is restricted. Coagulation depth can be increased by using large probes (10 rather than 7 French, although this requires an endoscope with a &gt;3.2 mm diameter instrument channel), using lower energy levels applied over a longer period of time, and using firmer contact (tamponade).</p><p>Coaptive coagulation is the goal of coagulation therapy of ulcers. By applying pressure directly over the vessel with the probe while applying cautery, the bleeding vessel is cauterized in a sealed state that does not allow for further blood flow. MPEC probes can be used perpendicularly or tangentially to the lesion being treated since the electrode tip allows for therapy with any angle of surface contact, though the angle may affect the ability to apply pressure.</p><p>The standard MPEC probe permits water irrigation at the tip of the probe that facilitates washing the bleeding site, permitting improved visualization and precise application of endoscopic therapy. To prevent the probe from sticking to the area that has been treated, water irrigation via the probe can be applied after each application of cautery to gently separate the probe from the underlying area before retracting the device.</p><p>A catheter that combines an MPEC probe with a retractable injection needle (the Injection-Gold probe) allows for the direct use of combination therapy (typically, dilute <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection in conjunction with thermal therapy) without having to exchange catheters. </p><p class="headingAnchor" id="H5"><span class="h2">Heater probe</span><span class="headingEndMark"> — </span>While used in the past, heater probes are no longer being produced. </p><p class="headingAnchor" id="H29109484"><span class="h2">Monopolar probe</span><span class="headingEndMark"> — </span>Monopolar probes designed for bleeding control are similar to hot biopsy forceps, except that the jaws are flat (not curved and cutting) and rotatable. Similar to other forms of monopolar technology (such as using a snare with cautery), a grounding pad is required. The electrocautery used in this technique is a soft coagulation mode which maximizes cautery without tissue carbonization or cutting. The technique for bleeding control is different than the other thermal contact devices in that the tissue for therapy is grasped with the forceps and pulled or "tented" away from the gastrointestinal wall or the vessel or the probe is placed next to the vessel and gentle pressure is applied using the closed tip of the hemostatic forceps. This device has been widely used to control bleeding during endoscopic maneuvers such as endoscopic submucosal dissection. Experience in controlling nonvariceal bleeding is growing and it appears that this is another effective modality for achieving hemostasis [<a href="#rid3">3-7</a>].</p><p class="headingAnchor" id="H158746320"><span class="h1">USE IN PATIENTS WITH IMPLANTED CARDIAC PACEMAKERS OR DEFIBRILLATORS</span><span class="headingEndMark"> — </span>When multipolar electrocautery is used, the current flow is localized to the area being treated, minimizing the risk of interaction between the probe and implanted cardiac devices. Unlike monopolar cautery devices, multipolar electrocautery does not require special precautions to prevent interference with the cardiac device. </p><p>No specific precautions are required in patients being treated with heater probes. A grounding pad is required for patients being treated with monopolar electrocautery. It is recommended that the patient plate (dispersive electrode) be placed on the lower extremity opposite the pacer/implantable cardioverter-defibrillator location to draw current away from the unit.</p><p class="headingAnchor" id="H63421629"><span class="h1">TECHNIQUES</span><span class="headingEndMark"> — </span>Thermal coagulation with multipolar or heater contact probes achieves acute hemostasis and prevents recurrent bleeding by coaptive coagulation of the underlying artery in the ulcer base  (<a class="graphic graphic_picture graphicRef79058" href="/z/d/graphic/79058.html" rel="external">picture 2B</a> and <a class="graphic graphic_picture graphicRef70660" href="/z/d/graphic/70660.html" rel="external">picture 2D</a>). It can be used in patients with active bleeding, a nonbleeding visible vessel, or to treat a vessel underneath an adherent clot (following clot removal).</p><p class="headingAnchor" id="H63426255"><span class="h2">Equipment</span><span class="headingEndMark"> — </span>The equipment required to perform hemostasis with a contact thermal device includes the endoscope (preferably a large-channel therapeutic scope), a multipolar electrocautery (MPEC) or heater probe, and an electrosurgical generator. Large diameter (3.2 mm or 10 French) thermal probes are preferable. Other equipment to have on hand includes endoscopic clips, an injection needle, snares (for adherent clot removal after <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection), epinephrine (diluted 1:10,000 to 1:100,000 for injection), and <a class="drug drug_general" data-topicid="8493" href="/z/d/drug information/8493.html" rel="external">glucagon</a> (for control of peristalsis).</p><p>In addition, a Doppler ultrasound probe may be helpful to confirm successful hemostasis, but is not required. </p><p class="headingAnchor" id="H63424264"><span class="h3">Choice of endoscope</span><span class="headingEndMark"> — </span>Endoscopic diagnosis and treatment of severe upper gastrointestinal bleeding is best performed with therapeutic gastroduodenoscopes that have a single large channel (3.7 to 6 mm diameter) or two channels (at least one large diameter). These endoscopes have a separate water jet for targeted irrigation of the bleeding site. A two-channel therapeutic endoscope permits high-volume suctioning through one channel, while a hemostatic probe is in the other channel.</p><p class="headingAnchor" id="H63425527"><span class="h3">Choice of probe</span><span class="headingEndMark"> — </span>Studies suggest similar efficacy with MPEC probes and heater probes [<a href="#rid8">8</a>]. In most cases, the choice between probes will depend on which equipment is available in a given endoscopy unit or hospital. MPEC probes can be used both perpendicularly and tangentially relative to the bleeding lesion, but heater probes can only be used perpendicularly. In addition, inadvertent deep cauterization may be less likely with MPEC probes than with heater probes because the depth of cauterization is limited by tissue desiccation, something that does not occur with heater probes. (See <a class="local">'Available devices'</a> above and <a class="local">'Efficacy'</a> below.)</p><p>When possible, it is preferable to use a large diameter probe (3.2 mm diameter or 10 French) through a therapeutic endoscope, although a smaller probe (2.3 mm diameter or 7 French) can be used through a standard endoscope. </p><p class="headingAnchor" id="H63424313"><span class="h3">Use of Doppler ultrasound</span><span class="headingEndMark"> — </span>Doppler ultrasound probes can be used to help determine the risk of continued or ongoing bleeding [<a href="#rid9">9,10</a>]. The probes help visualize the underlying blood flow to determine whether hemostasis is complete. </p><p>An endoscopic Doppler ultrasound probe consists of a thin catheter with an ultrasound probe at the tip that provides an auditory signal that can be advanced through the channel of an endoscope. It can be used to evaluate blood flow underlying the ulcer bed before and after treatment, with the goal of ablating the signal of vessel blood flow [<a href="#rid9">9-11</a>]. The Doppler ultrasound probe is complementary to clinical standard endoscopic assessment of bleeding risk. The risk of recurrent or ongoing bleeding is increased when underlying blood flow persists beneath the ulcer, whereas recurrent bleeding is less likely when blood flow is absent upon completion of hemostasis.</p><p>The use of Doppler ultrasound was evaluated in a randomized trial in patients with severe upper GI bleeding [<a href="#rid12">12</a>]. There were 148 patients evaluated (125 with ulcers, 19 with Dieulafoy's lesions, and 4 with Mallory Weiss tears). Doppler ultrasound was used in 72 patients, whereas the 76 patients in the control group underwent standard visually-guided hemostasis. Rebleeding within 30 days was less common in the Doppler group compared with the control group (11 versus 27 percent), with a number needed to treat to prevent one episode of rebleeding of seven. </p><p>Doppler probes may best be utilized to determine if adequate treatment has been delivered to high-risk lesions, particularly in patients at high risk for further bleeding or with multiple comorbidities and in patients with rebleeding. In addition, Doppler probes may be used to evaluate whether a lesion with questionable high-risk stigmata of hemorrhage needs treatment [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H63424927"><span class="h2">Application of thermal coagulation</span><span class="headingEndMark"> — </span>Thermal coagulation with contact probes achieves acute hemostasis and prevents recurrent bleeding by applying pressure to the vessel with the probe to compress it while coagulation is performed (coaptive coagulation). This results in sealing (coaptation) of the vessel  (<a class="graphic graphic_picture graphicRef79058" href="/z/d/graphic/79058.html" rel="external">picture 2B</a> and <a class="graphic graphic_picture graphicRef70660" href="/z/d/graphic/70660.html" rel="external">picture 2D</a>) [<a href="#rid14">14</a>]. Thermal coagulation is often used in combination with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection (combination therapy). </p><p>A potential advantage of combination therapy is that <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> is easy to administer and it can help slow or stop bleeding prior to the application of thermal therapy. During active bleeding, this may improve visualization, permitting targeted treatment of the bleeding site and result in more durable hemostasis. (See  <a class="medical medical_review" href="/z/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers", section on 'Injection therapy'</a>.)</p><p class="headingAnchor" id="H63425487"><span class="h3">Active bleeding or a nonbleeding visible vessel</span><span class="headingEndMark"> — </span>Once a bleeding site or nonbleeding visible vessel is identified (possibly after <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection), an MPEC probe is used to tamponade the site  (<a class="graphic graphic_picture graphicRef56986" href="/z/d/graphic/56986.html" rel="external">picture 6</a>). The probe is then activated via a foot pedal to cauterize the site. The power level and duration of cauterization varies depending on the lesion. For patients with active bleeding, the goal is to achieve hemostasis. In patients with a nonbleeding visible vessel, good coagulation with complete flattening of the vessel should be the visual endpoint  (<a class="graphic graphic_picture graphicRef79058 graphicRef70660" href="/z/d/graphic/79058.html" rel="external">picture 2B, 2D</a>).</p><p>Many of the electrosurgical generators used with MPEC probes come with preset settings based on which part of the gastrointestinal tract is being treated. If a generator with preset settings is not available, we use the following settings with MPEC probes [<a href="#rid15">15</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Active bleeding and nonbleeding visible vessel </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Gastric ulcer: Moderate to firm pressure, 15 to 20 watts, 10 seconds per pulse (prior to probe retraction), three to five pulses total</p><p class="bulletIndent2"><span class="glyph">•</span>Duodenal ulcer: Light to moderate pressure, 10 to 15 watts, 10 seconds per pulse (prior to probe retraction), three to five pulses total</p><p></p><p>Irrigation via the probe is used to wash the ulcer base, to release the probe to prevent sticking after cautery, and to facilitate repositioning of the probe for further treatment if bleeding continues. Targeted irrigation and suctioning of excess blood or fluid are extremely important to identify the specific bleeding site and focus the treatment. </p><p class="headingAnchor" id="H63425754"><span class="h3">Nonbleeding adherent clots</span><span class="headingEndMark"> — </span>One of the problems in assessing the risk for rebleeding in patients with an adherent clot is that the clot obscures the underlying ulcer stigmata. Nonbleeding vessels may be present underneath and are associated with a significantly higher rebleeding rate than minor stigmata, such as flat spots or clean ulcer bases [<a href="#rid16">16-22</a>]. Studies suggest improved outcomes when patients with adherent clots have the clots removed and receive appropriate treatment of underlying high-risk stigmata [<a href="#rid19">19-21</a>]. If the clot appears to be amenable to removal, our approach is to gently remove it and then treat any high-risk underling lesion. However, it is reasonable to not attempt removal of the clot if it is located in an area that is likely to be difficult to treat if bleeding is precipitated, if appropriate surgical or interventional radiology backup is not available, or if the endoscopist is not comfortable with the techniques used for clot removal. (See  <a class="medical medical_review" href="/z/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers", section on 'Stigmata of recent hemorrhage'</a> and  <a class="medical medical_review" href="/z/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers", section on 'Endoscopic therapy'</a>.)</p><p>We use the following approach for patients with nonbleeding adherent clots [<a href="#rid18">18</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Targeted jet irrigation is used to try to wash off parts of the clot with suction of any dislodged clots or blood. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dilute <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> (1:10,000 to 1:20,000 in <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>) is injected in four quadrants at the pedicle of the clot. The clot is then gently cold guillotined with a polypectomy snare (without electrocoagulation) to shave it down (avoiding shearing of the clot) to reveal any underlying stigmata. Only a portion of the clot is removed with each closing of the snare to decrease the risk of accidentally capturing the vessel within the snare.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Once the clot is removed, if there is active bleeding or a nonbleeding visible vessel, the site is treated with a contact thermal device (as described above) or an endoscopic clip. (See <a class="local">'Active bleeding or a nonbleeding visible vessel'</a> above and  <a class="medical medical_review" href="/z/d/html/2668.html" rel="external">"Endoscopic clip therapy in the gastrointestinal tract: Bleeding lesions and beyond", section on 'Technique'</a>.) </p><p></p><p>This technique of cold guillotine after <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection has been shown to be safe and does not induce the bleeding seen in earlier studies when clots were forcibly removed by other techniques [<a href="#rid19">19,20</a>]. Furthermore, it permits exposure and precise targeted treatment of the underlying ulcer stigmata.</p><p>An alternative to mechanically removing the clot is to irrigate the clot with 3 percent <a class="drug drug_general" data-topicid="113931" href="/z/d/drug information/113931.html" rel="external">hydrogen peroxide</a> using a spray catheter. Hydrogen peroxide acts by oxidizing hemoglobin, which makes the clot translucent and aids with its dissolution. While this technique has been shown to effectively remove the clot [<a href="#rid23">23</a>], it can be associated with patient discomfort and a significant amount of foaming, requiring washing before endoscopic therapy can be applied. Because of these limitations, we prefer removing clots using the cold guillotine method described above.</p><p class="headingAnchor" id="H63421685"><span class="h1">EFFICACY</span><span class="headingEndMark"> — </span>Treatment of bleeding peptic ulcers with contact thermal devices, either as monotherapy or in conjunction with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection, is associated with initial hemostasis in 78 to 100 percent of patients, with rebleeding rates of 0 to 18 percent [<a href="#rid2">2,7,24-30</a>]. Studies suggest that multipolar electrocoagulation and heater probes have similar efficacy rates [<a href="#rid8">8</a>]. </p><p class="headingAnchor" id="H63421693"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Complications of endoscopic therapy include perforation and precipitation (or worsening) of bleeding. In addition, <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> can cause tachycardia and arrhythmias. </p><p>While perforation with multipolar electrocautery is rare, it may precipitate bleeding in up to 18 percent of patients [<a href="#rid29">29</a>]. However, most cases of precipitated bleeding can be managed with additional endoscopic therapy. The perforation rate with heater probe coagulation may be as high as 2 to 3 percent, with provocation of bleeding in 5 percent [<a href="#rid31">31</a>].</p><p>Aggressive initial treatment or repeated applications of thermal or injection therapy may improve hemostasis, but also increase the risk of treatment-induced complications. Thus, predetermined limits (volume of injection solution, total treatment pulses, and total energy delivered) should be set and not exceeded for each technique in order to minimize the risk of complications. We usually do not exceed 20 mL of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> (1:10,000 dilution) injection or more than five applications of thermal coagulation. In patients at increased risk for cardiac complications from epinephrine, one option is to further dilute the epinephrine to 1:100,000.</p><p class="headingAnchor" id="H1305744763"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114134.html" rel="external">"Society guideline links: Gastrointestinal bleeding in adults"</a>.)</p><p class="headingAnchor" id="H27"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – The treatment of bleeding peptic ulcers includes resuscitation, treatment with acid suppressive therapy, and application of endoscopic therapy for patients at high risk of ongoing or recurrent bleeding  (<a class="graphic graphic_table graphicRef52860" href="/z/d/graphic/52860.html" rel="external">table 1</a>). Several endoscopic approaches can be used to treat bleeding peptic ulcers, including use of contact thermal devices, endoscopic clips, and <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection. (See  <a class="medical medical_review" href="/z/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers"</a> and  <a class="medical medical_review" href="/z/d/html/2668.html" rel="external">"Endoscopic clip therapy in the gastrointestinal tract: Bleeding lesions and beyond", section on 'Bleeding peptic ulcers'</a> and  <a class="medical medical_review" href="/z/d/html/2576.html" rel="external">"Argon plasma coagulation in the management of gastrointestinal hemorrhage"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Types of contact thermal devices</strong> – Three types of contact thermal devices have gained popularity due to their efficacy, safety profiles, ease of use, and portability (see <a class="local">'Available devices'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Multipolar electrocautery probes</p><p class="bulletIndent2"><span class="glyph">•</span>Heater probes (not currently being produced)</p><p class="bulletIndent2"><span class="glyph">•</span>Monopolar probes </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Technique</strong> – Thermal coagulation with contact probes achieves acute hemostasis and prevents recurrent bleeding by coaptive coagulation of the underlying artery in the ulcer base  (<a class="graphic graphic_picture graphicRef79058" href="/z/d/graphic/79058.html" rel="external">picture 2B</a> and <a class="graphic graphic_picture graphicRef70660" href="/z/d/graphic/70660.html" rel="external">picture 2D</a>). Coaptive coagulation involves applying pressure to the vessel with the probe to compress it while coagulation is performed. This results in sealing (coaptation) of the vessel. It can be used in patients with active bleeding, a nonbleeding visible vessel, or an adherent clot (following clot removal). (See <a class="local">'Techniques'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy </strong>– Treatment of bleeding peptic ulcers with contact thermal devices, either as monotherapy or in conjunction with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection, is associated with initial hemostasis in 78 to 100 percent of patients, with rebleeding rates of 0 to 18 percent  (<a class="graphic graphic_table graphicRef78607" href="/z/d/graphic/78607.html" rel="external">table 2</a>). Studies suggest that multipolar electrocoagulation and heater probes have similar efficacy rates. (See <a class="local">'Efficacy'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2:394.</a></li><li><a class="nounderline abstract_t">Asge Technology Committee, Conway JD, Adler DG, et al. Endoscopic hemostatic devices. Gastrointest Endosc 2009; 69:987.</a></li><li><a class="nounderline abstract_t">Saltzman JR, Thiesen A, Liu JJ. Determination of optimal monopolar coagulation settings for upper GI bleeding in a pig model. Gastrointest Endosc 2010; 72:796.</a></li><li><a class="nounderline abstract_t">Nunoue T, Takenaka R, Hori K, et al. A Randomized Trial of Monopolar Soft-mode Coagulation Versus Heater Probe Thermocoagulation for Peptic Ulcer Bleeding. J Clin Gastroenterol 2015; 49:472.</a></li><li><a class="nounderline abstract_t">Peng YC, Chen SW, Tung CF, et al. Comparison the efficacy of intermediate dose argon plasma coagulation versus hemoclip for upper gastrointestinal non-variceal bleeding. Hepatogastroenterology 2013; 60:2004.</a></li><li><a class="nounderline abstract_t">Yamasaki Y, Takenaka R, Nunoue T, et al. Monopolar soft-mode coagulation using hemostatic forceps for peptic ulcer bleeding. Hepatogastroenterology 2014; 61:2272.</a></li><li><a class="nounderline abstract_t">Toka B, Eminler AT, Karacaer C, et al. Comparison of monopolar hemostatic forceps with soft coagulation versus hemoclip for peptic ulcer bleeding: a randomized trial (with video). Gastrointest Endosc 2019; 89:792.</a></li><li><a class="nounderline abstract_t">Lin HJ, Wang K, Perng CL, et al. Heater probe thermocoagulation and multipolar electrocoagulation for arrest of peptic ulcer bleeding. A prospective, randomized comparative trial. J Clin Gastroenterol 1995; 21:99.</a></li><li><a class="nounderline abstract_t">Wong RC. Endoscopic Doppler US probe for acute peptic ulcer hemorrhage. Gastrointest Endosc 2004; 60:804.</a></li><li><a class="nounderline abstract_t">Jensen D, Ohning G, Singh B, et al. For severe UGI hemorrhage doppler ultrasound probe is more accurate for risk stratification and helpful for complete endoscopic hemostasis than lesion stigmata alone. Gastrointest Endosc 2008; 67:AB81:264.</a></li><li><a class="nounderline abstract_t">Jensen DM, Ohning GV, Kovacs TO, et al. Doppler endoscopic probe as a guide to risk stratification and definitive hemostasis of peptic ulcer bleeding. Gastrointest Endosc 2016; 83:129.</a></li><li><a class="nounderline abstract_t">Jensen DM, Kovacs TOG, Ohning GV, et al. Doppler Endoscopic Probe Monitoring of Blood Flow Improves Risk Stratification and Outcomes of Patients With Severe Nonvariceal Upper Gastrointestinal Hemorrhage. Gastroenterology 2017; 152:1310.</a></li><li><a class="nounderline abstract_t">Nayor J, Saltzman JR. Should We All Be Using the Doppler Endoscopic Probe in Nonvariceal Upper Gastrointestinal Bleeding? Gastroenterology 2017; 152:1280.</a></li><li><a class="nounderline abstract_t">Llach J, Bordas JM, Salmerón JM, et al. A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage. Gastrointest Endosc 1996; 43:117.</a></li><li><a class="nounderline abstract_t">Morris ML, Tucker RD, Baron TH, Song LM. Electrosurgery in gastrointestinal endoscopy: principles to practice. Am J Gastroenterol 2009; 104:1563.</a></li><li><a class="nounderline abstract_t">Jensen DM. Where next with endoscopic ulcer hemostasis? Am J Gastroenterol 2002; 97:2161.</a></li><li><a class="nounderline abstract_t">Jensen DM, Machicado GA. Endoscopic Hemostasis of Ulcer Hemorrhage with Injection, Thermal, or Combination Methods. Techniques in Gastrointestinal Endoscopy 2005; 7:124.</a></li><li><a class="nounderline abstract_t">Sung JJ, Barkun A, Kuipers EJ, et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 2009; 150:455.</a></li><li><a class="nounderline abstract_t">Jensen DM, Kovacs TO, Jutabha R, et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002; 123:407.</a></li><li><a class="nounderline abstract_t">Bleau BL, Gostout CJ, Sherman KE, et al. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc 2002; 56:1.</a></li><li><a class="nounderline abstract_t">Kahi CJ, Jensen DM, Sung JJ, et al. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis. Gastroenterology 2005; 129:855.</a></li><li><a class="nounderline abstract_t">Laine L, Stein C, Sharma V. A prospective outcome study of patients with clot in an ulcer and the effect of irrigation. Gastrointest Endosc 1996; 43:107.</a></li><li><a class="nounderline abstract_t">Sridhar S, Chamberlain S, Thiruvaiyaru D, et al. Hydrogen peroxide improves the visibility of ulcer bases in acute non-variceal upper gastrointestinal bleeding: a single-center prospective study. Dig Dis Sci 2009; 54:2427.</a></li><li><a class="nounderline abstract_t">Chung SS, Lau JY, Sung JJ, et al. Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ 1997; 314:1307.</a></li><li><a class="nounderline abstract_t">Lin HJ, Tseng GY, Perng CL, et al. Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding. Gut 1999; 44:715.</a></li><li><a class="nounderline abstract_t">Fullarton GM, Birnie GG, Macdonald A, Murray WR. Controlled trial of heater probe treatment in bleeding peptic ulcers. Br J Surg 1989; 76:541.</a></li><li><a class="nounderline abstract_t">Jaramillo JL, Carmona C, Gálvez C, et al. Efficacy of the heater probe in peptic ulcer with a non-bleeding visible vessel. A controlled, randomised study. Gut 1993; 34:1502.</a></li><li><a class="nounderline abstract_t">Laine L. Multipolar electrocoagulation in the treatment of active upper gastrointestinal tract hemorrhage. A prospective controlled trial. N Engl J Med 1987; 316:1613.</a></li><li><a class="nounderline abstract_t">Laine L. Multipolar electrocoagulation in the treatment of peptic ulcers with nonbleeding visible vessels. A prospective, controlled trial. Ann Intern Med 1989; 110:510.</a></li><li><a class="nounderline abstract_t">Tekant Y, Goh P, Alexander DJ, et al. Combination therapy using adrenaline and heater probe to reduce rebleeding in patients with peptic ulcer haemorrhage: a prospective randomized trial. Br J Surg 1995; 82:223.</a></li><li><a class="nounderline abstract_t">Chung SC, Leung JW, Sung JY, et al. Injection or heat probe for bleeding ulcer. Gastroenterology 1991; 100:33.</a></li></ol></div><div id="topicVersionRevision">Topic 2589 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4136718" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Endoscopy in gastrointestinal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19410037" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Endoscopic hemostatic devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20573346" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Determination of optimal monopolar coagulation settings for upper GI bleeding in a pig model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25083773" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : A Randomized Trial of Monopolar Soft-mode Coagulation Versus Heater Probe Thermocoagulation for Peptic Ulcer Bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24719941" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Comparison the efficacy of intermediate dose argon plasma coagulation versus hemoclip for upper gastrointestinal non-variceal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25699366" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Monopolar soft-mode coagulation using hemostatic forceps for peptic ulcer bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30342026" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Comparison of monopolar hemostatic forceps with soft coagulation versus hemoclip for peptic ulcer bleeding: a randomized trial (with video).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8583095" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Heater probe thermocoagulation and multipolar electrocoagulation for arrest of peptic ulcer bleeding. A prospective, randomized comparative trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15557966" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Endoscopic Doppler US probe for acute peptic ulcer hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : For severe UGI hemorrhage doppler ultrasound probe is more accurate for risk stratification and helpful for complete endoscopic hemostasis than lesion stigmata alone</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26318834" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Doppler endoscopic probe as a guide to risk stratification and definitive hemostasis of peptic ulcer bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28167214" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Doppler Endoscopic Probe Monitoring of Blood Flow Improves Risk Stratification and Outcomes of Patients With Severe Nonvariceal Upper Gastrointestinal Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28351653" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Should We All Be Using the Doppler Endoscopic Probe in Nonvariceal Upper Gastrointestinal Bleeding?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8635703" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19491874" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Electrosurgery in gastrointestinal endoscopy: principles to practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12358226" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Where next with endoscopic ulcer hemostasis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Endoscopic Hemostasis of Ulcer Hemorrhage with Injection, Thermal, or Combination Methods</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19221370" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12145792" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12085028" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16143125" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8635701" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A prospective outcome study of patients with clot in an ulcer and the effect of irrigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19757051" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Hydrogen peroxide improves the visibility of ulcer bases in acute non-variceal upper gastrointestinal bleeding: a single-center prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9158465" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10205211" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2667687" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Controlled trial of heater probe treatment in bleeding peptic ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8244132" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Efficacy of the heater probe in peptic ulcer with a non-bleeding visible vessel. A controlled, randomised study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3295547" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Multipolar electrocoagulation in the treatment of active upper gastrointestinal tract hemorrhage. A prospective controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2647014" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Multipolar electrocoagulation in the treatment of peptic ulcers with nonbleeding visible vessels. A prospective, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7749698" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Combination therapy using adrenaline and heater probe to reduce rebleeding in patients with peptic ulcer haemorrhage: a prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1983848" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Injection or heat probe for bleeding ulcer.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
